Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
AKBA
Stock Latest News
Company Announcements
Akebia Therapeutics Balances Vafseo Momentum With Headwinds
9d ago
AKBA
Premium
The Fly
Akebia reports Q1 EPS (3c), consensus 0c
10d ago
AKBA
Premium
Pre-Earnings
Is AKBA a Buy, Before Earnings?
12d ago
AKBA
Premium
The Fly
Akebia doses first participants in AKB-9090 trial
1M ago
AKBA
Premium
Ratings
Akebia (AKBA): Buy Rating Backed by Vafseo Momentum and High-Value Renal Pipeline Upside
1M ago
AKBA
Premium
Company Announcements
Akebia Therapeutics Earnings Call: Vafseo Drives Growth
2M ago
AKBA
Premium
Market News
3 Best Stocks to Buy Today with 125%+ Upside, 2/27/2026, According to Top Analysts
3M ago
AKBA
BDSX
Premium
The Fly
Akebia reports Q4 EPS (5c), consensus (4c)
3M ago
AKBA
Premium
The Fly
Akebia price target lowered to $4 from $5 at BTIG
3M ago
AKBA
Premium
Pre-Earnings
Akebia Therapeutics (AKBA) Q4 Earnings Cheat Sheet
3M ago
AKBA
Premium
Company Announcements
Akebia’s Praliciguat FSGS Trial Moves Forward, Adding Optionality to the Kidney Pipeline
3M ago
AKBA
Premium
The Fly
Akebia price target lowered to $4 from $6 at Piper Sandler
3M ago
AKBA
Premium
Company Announcements
Akebia Therapeutics Updates Executive Severance and Leadership Terms
4M ago
8K
AKBA
Premium
The Fly
Akebia announces corporate updates, 2026 pipeline outlook
4M ago
AKBA
Premium
Company Announcements
Akebia Therapeutics Outlines 2026 Vafseo Strategy and Pipeline
4M ago
8K
AKBA
Premium
Ratings
Akebia Therapeutics: Advancing Praliciguat in FSGS and Vafseo Commercial Ramp Support Compelling Buy Thesis
4M ago
AKBA
Premium
The Fly
Akebia announces first patient dosed in Phase 2 trial of praliciguat
4M ago
AKBA
Premium
Ratings
Strategic Expansion and Market Potential Drive Buy Rating for Akebia Therapeutics
6M ago
AKBA
Premium
Company Announcements
Akebia Therapeutics Acquires Global Rights to ADX-097
6M ago
8K
AKBA
Premium
The Fly
Akebia Therapeutics announces establishment of rare kidney disease pipeline
6M ago
AKBA
QTTB
Premium
The Fly
Q32 Bio sells complement inhibitor ADX-097 to Akebia for $12M upfront
6M ago
AKBA
QTTB
Premium
The Fly
Q32 Bio sells complement inhibitor ADX-097 to Akebia
6M ago
AKBA
QTTB
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
